Local ablative therapy integrated with first-line EGFR TKI improves progression-free survival and overall survival
Adding local treatment to lung cancer drugs improves survival
This systematic review and meta-analysis of 31 studies indicates that integrating local ablative therapy (LAT) with first-line EGFR tyrosine…
Combining local ablative therapy with targeted drugs may help patients with specific lung cancer mutations live longer.
Systematic review of lung cancer in pregnancy reports treatment patterns and outcomes
Women with lung cancer during pregnancy need careful treatment plans and close medical care for best results
This systematic review synthesized 96 cases of lung cancer diagnosed during pregnancy. It found that 58.9% had actionable driver alterations…
A review of ninety-six cases shows most mothers had advanced cancer when diagnosed. Many received chemotherapy or targeted drugs safely, wit…